Application

15315264 · PHARMACEUTICAL COMPOSITION WITH IONICALLY CROSSLINKED POLYMER ENCAPSULATION OF ACTIVE INGREDIENT

Filed 2016-11-30 · Abandoned The official file ↗ · Art unit 1616 · Examiner Abigail Louise Vanhorn Typical · CPC A61K 9/006 · CURE Pharmaceutical Corporation · Nixon Peabody LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

7.6 mo

to disposition 43.5 mo

Statutes raised

102 103 112

5 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.